FDA Approves Treatment for Children and Teens With Mildly to Moderately Active Ulcerative Colitis FDA today approved Colazal (balsalazide disodium) for the treatment of mildly to moderately active ulcerative colitis in patients 5 to 17 years of age.
Original post by News Editor
0 Responses to “FDA Approves Treatment for Children and Teens With Mildly to”